SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-045222
Filing Date
2017-02-15
Accepted
2017-02-15 16:05:56
Documents
3
Period of Report
2017-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d344500d8k.htm 8-K 16704
2 EX-99.1 d344500dex991.htm EX-99.1 110741
3 GRAPHIC g344500g0215211732159.jpg GRAPHIC 4541
  Complete submission text file 0001193125-17-045222.txt   135015
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 17614682
SIC: 2834 Pharmaceutical Preparations